Carnitine deficiency; metabolic and exercise research
Human evidence
Levocarnitine has established deficiency-related medical uses and disease-specific randomized evidence. Trials also show that biochemical repletion does not guarantee symptomatic benefit in every population.
Regulatory status
FDA records licensed Carnitor/levocarnitine for primary/secondary carnitine deficiency and some dialysis-associated deficiency contexts.
Main limitations
General fat-loss, performance or mitochondrial-enhancement benefit in healthy people from disease-specific evidence.
Safety
Adverse effects are route/dose specific; broad wellness use should not be conflated with treatment of deficiency.
i
Levocarnitine has established deficiency-related medical uses and disease-specific randomized evidence. Trials also show that biochemical repletion does not guarantee symptomatic benefit in every population.
What the evidence actually supports
✓Target engagement does not guarantee symptom benefit.
✓Separate deficiency treatment from lifestyle marketing.
What is not established / key limitations
×Primary efficacy analysis was negative.
×Does not establish performance, weight-loss or mitochondrial-enhancement benefits in healthy people.
Selected study & evidence records
L-carnitine supplementation in advanced cancer with carnitine deficiency
2009 · Randomized, double-blind, placebo-controlled study · n=29
The prespecified intent-to-treat analysis found no significant improvement in study endpoints despite increased serum carnitine.
Adverse effects are route/dose specific; broad wellness use should not be conflated with treatment of deficiency.
Adverse effects are route/dose specific; broad wellness use should not be conflated with treatment of deficiency.
Technical details
Mechanism / biologyTransports long-chain fatty acids into mitochondria for beta-oxidation.
Route / formulation boundaryRoute matters: oral and injectable levocarnitine have different formulations, evidence bases and product requirements.
Identity / data-quality noteUse the canonical compound identity and studied formulation when interpreting evidence.
Dosing evidence statusVerified dosing evidence added. UK licensed paediatric deficiency dosing example. See dosing_evidence records for route, regimen, population, duration and source.
Evidence rule: WhichPeps keeps human, animal, laboratory, regulatory and product/formulation evidence distinct. Common names help people find the page; they do not change the underlying scientific identity.
